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Summary
 
Somatic hypermutation of Ig genes is probably dependent on transcription of the target gene
via a mutator factor associated with the RNA polymerase (Storb, U., E.L. Klotz, J. Hackett, Jr.,
K. Kage, G. Bozek, and T.E. Martin. 1998. 
 
J. Exp. Med.
 
 188:689–698). It is also probable that
some form of DNA repair is involved in the mutation process. It was shown that the nucleo-
tide excision repair proteins were not required, nor were mismatch repair (MMR) proteins.
However, certain changes in mutation patterns and frequency of point mutations were observed
in Msh2 (MutS homologue) and Pms2 (MutL homologue) MMR-deficient mice (for review
see Kim, N., and U. Storb. 1998. 
 
J. Exp. Med. 
 
187:1729–1733). These data were obtained
from endogenous immunoglobulin (Ig) genes and were presumably influenced by selection of
B cells whose Ig genes had undergone certain mutations. In this study, we have analyzed somatic
hypermutation in two MutL types of MMR deficiencies, Pms2 and Mlh1. The mutation target
was a nonselectable Ig-
 
k
 
 gene with an artificial insert in the V region. We found that both
Pms2- and Mlh1-deficient mice can somatically hypermutate the Ig test gene at approximately
twofold reduced frequencies. Furthermore, highly mutated sequences are almost absent. To-
gether with the finding of genome instability in the germinal center B cells, these observations
support the conclusion, previously reached for Msh2 mice, that MMR-deficient B cells under-
going somatic hypermutation have a short life span. Pms2- and Mlh1-deficient mice also re-
semble Msh2-deficient mice with respect to preferential targeting of G and C nucleotides. Thus,
it appears that the different MMR proteins do not have unique functions with respect to so-
matic hypermutation. Several intrinsic characteristics of somatic hypermutation remain unaltered
in the MMR-deficient mice: a preference for targeting A over T, a strand bias, mutational hot
spots, and hypermutability of the artificial insert are all seen in the unselectable Ig gene. This
implies that the MMR proteins are not required for and most likely are not involved in the pri-
mary step of introducing the mutations. Instead, they are recruited to repair certain somatic
point mutations, presumably soon after these are created.
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I
 
mmunoglobulin (Ig) genes are first rearranged in early B
cell development through the V(D)J recombination pro-
cess and then further modified upon antigenic stimulation
through the somatic hypermutation process. The mutation
process is active in the germinal center (GC)
 
1
 
 of secondary
lymphoid organs such as lymph nodes, the spleen, and Peyer’s
patches (1). Mutations accumulated in Ig genes, coupled
with antigen-dependent clonal selection, result in affinity
maturation. B cells that have acquired mutations in the Ig
gene variable region leading to higher affinity antibodies
are preferentially selected for further differentiation and pro-
liferation (1). Somatic hypermutations primarily consist of
single substitutions introduced to rearranged Ig genes and
are confined to 
 
z
 
1.5 kb downstream of the transcription
start site (for review see reference 2). There is also evidence
for a strand bias that can be detected as there is an A over T
bias (3), although in some cases such bias was not observed
(4). Certain short sequences are hot spots of mutation, such
as the AGY trinucleotide (5).
Transcription has been shown to be closely linked to the
Ig somatic mutation process through the study of Ig trans-
genic mice. Notably, Peters and Storb demonstrated that
 
1
 
Abbreviations used in this paper:
 
 GC, germinal center; MMR, mismatch re-
pair; NER, nucleotide excision repair; SSR, simple sequence repeat. 
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mutation can be directed to the constant region of an Ig
transgene by duplication of the Ig promoter just upstream
of the constant region exon (6). In another study of trans-
genic mouse lines, Fukita et al. (7) showed that deletion of
the promoter in an otherwise intact Ig transgene results in a
greatly reduced mutation rate. In conjunction with earlier
reports concerning the importance of Ig transcriptional en-
hancers in the mutation process (8), the findings suggest
that the Ig somatic mutation process is coupled to the tran-
scription process. It has been proposed that the molecular
mechanism of the somatic hypermutation of Ig genes in-
volves DNA repair processes in addition to transcription.
One such proposed model invoked gratuitous transcrip-
tion-coupled repair as a key step in the introduction of mu-
tations (6). However, studies of human cell lines and mice
deficient in nucleotide excision repair (NER) have shown
that, although NER is known to be involved in transcrip-
tion-coupled repair (9), it is not required for Ig somatic
mutation (10–14).
Although NER is responsible for repairing DNA dam-
age with bulky adducts such as UV photoproducts (15),
postreplication mismatch repair (MMR) is responsible for
correcting misincorporation or slippage errors introduced
during the replication phase of the cell cycle (16). In 
 
Esche-
richia coli
 
, three genes are essential for MMR function, 
 
mutS
 
,
 
mutL
 
, and 
 
mutH
 
 (16). MutS, the protein that recognizes mis-
paired bases, forms a functional MMR complex with MutL
and MutH. MutH is an endonuclease that recognizes
hemimethylated DNA. This allows the correct repair of
newly synthesized, unmethylated strands of DNA. In hu-
mans, mutations in homologues of 
 
mutS
 
 or 
 
mutL
 
 have
been identified in patients with hereditary nonpolyposis
colorectal cancer. The mouse 
 
Msh2
 
 gene (
 
mutS
 
 homologue),
 
Mlh1
 
 gene (
 
mutL
 
 homologue), and 
 
Pms2
 
 gene (
 
mutL
 
 ho-
mologue) have been individually studied in gene disruption
experiments (17–19). These MMR-deficient mice show
microsatellite instability, spontaneous tumors, and various
sterility problems. Surprisingly, Mlh1 deficiency and Pms2
deficiency result in different types of spontaneous tumors
and different types of sterility problems in spite of their bio-
chemical function being very closely related. Recently,
several labs have reported that mismatch-deficient mice,
Msh2
 
2/2
 
 or Pms2
 
2/2
 
, display normal frequencies of Ig so-
matic hypermutation but an altered spectrum of mutations
(13, 14, 20–22). Such results point to a possible role of the
MMR mechanism in somatic hypermutations of Ig genes
in the introduction, the repair, or the “fixing” of mutations.
However, the previous studies of Ig mutation in MMR-
deficient mice involved sequence analysis of endogenous Ig
genes. Therefore, the question of altered mutation pattern is
clouded by the issue of selection. To determine the direct
effect of MMR deficiency on Ig somatic hypermutation,
we have analyzed mutation patterns of a passenger trans-
gene that can be targeted for Ig mutation but, due to a pre-
mature stop codon, does not interfere with selection. We
have also compared the effect of 
 
Mlh1
 
 deficiency on so-
matic mutations in chronically stimulated Peyer’s patch B
lymphocytes to those in B lymphocytes in the spleen.
 
Materials and Methods
 
Mice.
 
Mlh1 and Pms2 knockout mice were provided by Dr.
R.M. Liskay (Oregon Health Sciences University, Portland,
OR). Heterozygote males and females were bred and offspring
were genotyped using a PCR-based method as previously de-
scribed (17, 18). The mice were kept in a conventional mouse
colony and are summarized in Table I. For the study of splenic
GC B cells, mice were immunized twice by intraperitoneal injec-
tion of 2 
 
3
 
 10
 
8
 
 SRBCs (ICN Biomedicals) on days 1 and 8 and
killed 7 d after the second immunization.
 
Isolation of GC B Cells.
 
Single cell suspensions from spleens
or Peyer’s patches were stained with PE-conjugated anti-B220
(CD45R) antibody (GIBCO BRL), FITC-conjugated PNA (Sigma
Chemical Co.), and FITC-conjugated GL7 antibody (PharMin-
gen). B220
 
1
 
/(PNA GL7)
 
high
 
 cells were isolated using FACStar
 
plus
 
(Becton Dickinson). For the study of the Vk167/PEPS transgene
in splenic GC B cells, the depletion of subsets of cells was carried
out before FACS
 
®
 
 as described by Jacobs et al. (13) except for the
following changes. T cells (Thy1.2
 
1
 
), B1 cells (CD5
 
1
 
), macro-
phages (Mac3
 
1
 
), and virgin B cells (IgM
 
1
 
, IgD
 
1
 
) were depleted
from the splenic cells by the magnetic-activated cell sorting
method. A single cell suspension was first incubated with biotiny-
lated antibodies to Thy1.2, CD5, Mac3, sIgM, or sIgD (Phar-
Mingen) and then incubated with streptavidin-coated magnetic
beads (Dynal). Cells bound by beads were depleted by a strong
magnet and cells free of beads were used in GC B cell isolation as
described above.
 
PCR Amplification.
 
The synthesis of cDNA was carried out as
suggested in the Superscript II kit (Stratagene) using oligo d(T)16
primer (PE Applied Biosystems). Amplification of the VH11
gene from the cDNA was carried out as previously described by
Rogerson (23).
560-bp fragments of the Vk167/PEPS transgene containing
EPS sequences were amplified with Pfu DNA polymerase (Strat-
agene) and 5
 
9
 
 primer Vk3B (5
 
9
 
 GTCAGTGGGGATATTGT-
GATAACC) and 3
 
9 
 
primer EKVK2 (5
 
9
 
 TCAACTGATAAT-
GAGCCCTC). Both primers were phosphorylated in reactions
containing 1 mM ATP and T4 polynucleotide kinase (New En-
gland Biolabs) before the PCR reaction. PCR conditions were
30 cycles of 94
 
8
 
C for 15 s, 62
 
8
 
C for 20 s, and 72
 
8
 
C for 30 s.
All PCR-generated fragments were cloned by blunt end liga-
tion into the Srf1 site of pCRscript (Stratagene) or the Sma1 site
of pKS(
 
1
 
). Ligation reaction mixtures contained T4 DNA ligase
and either SrfI or SmaI (New England Biolabs) in order to mini-
mize vector religation.
 
EcoRV/PvuII Restriction Site Analysis.
 
Analysis of the EPS in
Vk167/PEPS transgene has been previously described (24). In
brief, each plasmid clone with the 560-bp fragment insert of the
transgene was amplified using primers Vk8B (5
 
9 
 
GTTTCAG-
CTCCAGCTTG) and Vk9B (5
 
9
 
 CTCCTCAGCTCCTGATC)
(35 cycles of 94
 
8
 
C for 20 s, 60
 
8
 
C for 30 s, and 72
 
8
 
C for 30 s). The
PCR product was digested with either EcoRV or PvuII (New
England Biolabs) and separated on a nondenaturing 18% polyacryl-
amide/5% glycerol gel and visualized by ethidium bromide stain-
ing. Mutation at one of the restriction sites results in disappearance
of smaller bands and/or appearance of larger bands (see Fig. 2 B).
 
Single Strand Conformation Polymorphism.
 
Single strand con-
formation polymorphism (SSCP) analysis was carried out accord-
ing to Orita et al. (25) with the following modifications in the
protocol: plasmid DNA was amplified with Vk3B and EkVk2
primers in 10 
 
m
 
l reactions containing PFU DNA polymerase, 2 mM
of each dNTP, and 1 
 
m
 
Ci of [
 
a
 
-
 
32
 
P]dCTP. PCR conditions were
as described above. PCR products were digested with restriction 
23
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endonuclease Taq
 
a
 
I (New England Biolabs) at 65
 
8
 
C, which re-
sults in two fragments of 300 and 260 bp, respectively. Digested
PCR products were diluted with dilution solution (10 mM
EDTA, 0.1% SDS) and stop solution (95% formamide, 20 mM
NaOH, 20 mM EDTA, 0.15% bromophenol blue, and 0.15%
xylene cyanol). The mixture was denatured by incubation at
98
 
8
 
C for 10 min and quick chill on ice. Resolution was carried out
by electrophoresis through a 6% polyacrylamide/10% glycerol gel
at 6 W for 17–19 h. The gel was dried and exposed to Kodak X
OMAT film (Eastman-Kodak Co.).
 
Sequencing.
 
Sequencing was carried out either manually using
the Sequenase II Dideoxy Terminator Sequencing kit (United States
Biochemical Corp.) or by University of Chicago Cancer Research
Center DNA Sequencing Facility using ABI Prism model 377 se-
quencer (Applied Biosystems, Inc.). The sequencing primers T7, T3,
or reverse primer were used. The reverse primer (5
 
9
 
 GGAAAC-
AGCTATGACCATG 3
 
9
 
) is a primer just upstream of the T3
primer in the multiple cloning site of pKSII(
 
1
 
) or pCRSCRIPT.
 
Microsatellite Analysis.
 
Oligonucleotide primers (D4Mit42F
and D4Mit42R) specific to simple sequence repeat (SSR) locus
D4Mit42 were obtained from Research Genetics. Before the
PCR reaction, the D4Mit42F primer was phosphorylated with
T4 Polynucleotide Kinase (New England Biolabs) and [
 
g
 
-
 
32
 
P]
ATP. PCR reaction contained 1 pmol each of labeled D4Mit42F
primer and unlabeled D4Mit42R primer, 0.2 mM of each
dNTP, 0.25 U of Taq polymerase, and 20–40 pg of DNA in a
total vol of 10 
 
m
 
l. The PCR conditions were 32 cycles of 15 s at
94
 
8
 
C, 30 s at 55
 
8
 
C, and 30 s at 72
 
8
 
C. The products were sepa-
rated on a 6% polyacrylamide denaturing sequencing gel and ex-
posed to phosphor screen (Molecular Dynamics). The image was
 
visualized by scanning with a Storm 860 scanner and analyzed by
ImageQuant software (Molecular Dynamics).
 
Results
 
Normal Somatic Hypermutations in Endogenous Heavy Chain
Variable Gene.
 
Somatic hypermutation of an endogenous
Ig gene was studied in knockout mice twice immunized
with SRBCs. B220
 
1
 
PNA
 
hi
 
 B cells, which represent the GC
B cell compartment, were isolated from spleens of Mlh1
 
2/2
 
or Pms2
 
2/2
 
 mice. RNA was extracted from these cell popu-
lations and the VH11 gene, which is a member of the S107
family of heavy chain variable genes, was amplified by the
reverse transcription PCR method and cloned for sequenc-
ing. In addition to the S107 family gene–specific primer, a
primer specific to the 
 
g
 
 constant region was used in amplifi-
cation so that only the VH11 gene sequences from activated
B cells that have switched to the 
 
g
 
 constant region would be
represented. Sequence analysis showed normal frequencies of
somatic hypermutation in Pms2
 
2/2
 
 as well as in Mlh1
 
2/2
 
mice (Fig. 1). The frequencies of somatic hypermutation in
the clones analyzed were 0.7% in Pms2
 
2/2
 
 mice and 1% in
Mlh1
 
2/2
 
 mice. Comparable mutation frequencies were pre-
viously reported for VHS107 genes in GC B lymphocytes of
wild-type mice immunized in the same way (23). Inciden-
tally, five out of six Mlh1
 
2/2
 
 clones sequenced were poten-
tially related clones containing the same VDJ junction and
 
Table I.
 
Mice Used in This Study
 
Experiment
Mice
Genotype No. Name
 
*
 
Sex Age Genetic background
 
‡
 
S107 analysis Mlh1
 
2
 
/
 
2
 
1 E717 male 11 wk B6
Pms2
 
2
 
/
 
2
 
1 E661 male 8 wk B6
EPS analysis,
spleen Wt 3 #63 male 10 wk (CD1
 
3
 
B6)F1
 
{
 
E834 (Pms2
 
1
 
/
 
2
 
) male 14 wk
 
z
 
25% CD1
E840 (Pms2
 
1
 
/
 
1
 
) male 14 wk
 
z
 
25% CD1
Mlh1
 
2
 
/
 
2
 
2
 
{
 
E976 male 12 wk
 
z
 
12.5% CD1
A005 male 12 wk
 
z
 
12.5% CD1
Pms2
 
2
 
/
 
2
 
2
 
{
 
E931 male 9 mo
 
z
 
25% CD1
E842 female 6.5 mo
 
z
 
25% CD1
EPS analysis,
Peyer’s patches Wt 1 A144 (Mlh1
 
1
 
/
 
1
 
) male 14 wk
 
z
 
12.5% CD1
Mlh1
 
2
 
/
 
2
 
2 {
A145 female 14 wk z12.5% CD1
A146 male 14 wk z12.5% CD1
The EPS founder (PEPS4; reference 24) was CD1 background. It was crossed with B6, as were its offspring. For the crosses with Pms21/2 mice
(B6), a (CD1-PEPS4 3 B6)F1 was used in the first generation and brother–sister mating was used in subsequent crosses to result in Pms22/2 (or
Pms21/2, or Pms21/1) PEPS4 mice. For the crosses with Mlh11/2 mice, a (CD1-PEPS4 3 B6)F1 3 B6 mouse was used in the first generation and
brother–sister (or cousin–cousin) mating was used in the subsequent crosses to result in Mlh12/2 (or Mlh11/1) PEPS4 mice.
*Organs (spleens or Peyer’s patches) of mice marked by brackets were pooled.
‡The Mlh12/2 and Pms22/2 mice originated in strain 129/Sv and had been exhaustively crossed with C57BL/6 (B6) mice.24 Somatic Hypermutation and DNA Repair
sharing some identical mutations. As a control, the VH11
gene was amplified from a B2201PNAlo population using
VH11 and m constant region–specific primers and no muta-
tion was found in five sequenced clones (data not shown).
MLH1- or PMS2-deficient Mice Have a Near Normal Fre-
quency of Mutation But Altered Patterns. By analysis of VH11
gene clones, we have confirmed that the disruption of the
Mlh1 gene or of the Pms2 gene does not have a significant
effect on the frequency of Ig somatic mutation. To address
the issue of altered mutation spectra without the complica-
tion of selection, we decided to pursue the analysis of a pas-
senger transgene in the MMR-deficient strains of mice.
The Vk167/PEPS transgene contains an insertion of a
108-bp artificial sequence within a rearranged k light chain
transgene (Fig. 2 A). The insertion, termed EPS, contains
multiple EcoRV and PvuII sites that allow the detection of
mutation by restriction fragment length variance. Of 108 bp
in EPS, 76 bp lie in EcoRV or PvuII recognition sites.
Mutation at any one of these positions results in the loss of
the particular restriction site (Fig. 2 B). Previous study of
one transgenic mouse line, PEPS4, which carries four cop-
ies of the Vk167/PEPS transgene, showed that this trans-
gene can be targeted for Ig somatic hypermutation (24, 26).
Furthermore, the 108-bp EPS portion of the transgene
showed a mutation frequency z10 times higher than the
rest of the transgene sequences analyzed (Table II) (24, 26).
Mice heterozygous for Mlh1 or Pms2 disruption were
bred with the PEPS4 line of transgenic mice. Mice homo-
zygous for the disrupted allele and positive for the trans-
gene were immunized twice with SRBCs and killed 7 d af-
ter the second immunization for harvest of the spleens. We
enriched for activated GC B lymphocytes from splenic cells
by depleting T cells, B1 cells, macrophages, and virgin B
cells. Activated GC B lymphocytes were isolated from this
enriched population by fluorescence-activated cell sorting.
A part of the transgene was amplified with Pfu high fidelity
DNA polymerase from the DNA of these GC B cells and
cloned for analysis. Identification of mutations in the EPS
was carried out as previously described. Approximately 1
out of 30 clones analyzed was identified to have mutations in
one of the restriction sites. Subsequently, z560 bp of each
transgene clone including EPS and flanking Ig gene se-
quences were sequenced. A total of 26 clones were se-
quenced from Mlh12/2 mice and 15 clones from Pms22/2
mice with total numbers of mutations identified being 41
and 27 respectively (Fig. 3 and Table II). Mutation fre-
quencies were 2.9 3 1023 for Mlh12/2 mice and 3.3 3
1023 for Pms22/2 mice. These are approximately twofold
lower than 4.7 3 1023, which is the frequency we ob-
served in wild-type mice in a previous study (P , 0.0005
for Mlh12/2 and Pms22/2) (26). We did not find increased
Figure 1. Analysis of VH11 gene mutations. A VH11 sequence is rep-
resented by each line. The locations of mutations are indicated by arrows
with the specific nucleotide change written above each arrow. The solid
line represents the sequenced region and the dotted line represents the
unanalyzed sequence. All clones represented in this figure are of the IgG
isotype. (A) VH11 clones from Mlh12/2 mice. (B) VH11 clones from
Pms22/2 mice.
Figure 2. Map of the Vk167/PEPS transgene and EPS analysis. (A) Vk167/PEPS transgene and sequence of the EPS insert. The restriction sites within
the EPS are indicated. (B) An example of PAGE from an EPS analysis. PCR products from nine clones were digested with EcoRV (E) or PvuII (P) and
resolved in 18% acrylamide gel. Unmutated clones (12G, 2E, 2B, and 2D) show two large bands flanking the EPS region and ladders of small bands. In
case of EcoRV digestion, the small bands are 20, 18, 16, 14, 12, and 10 bp (12- and 10-bp bands are invisible here). In case of PvuII digestion, the small
bands are 19, 17, 15, 13, and 11 bp (11-bp bands are invisible). An asterisk indicates mutated clones. Clone 8G, for example, has a mutation in the fourth
PvuII site (PD), so the 15- and 17-bp bands are gone and a 32-bp band has appeared.25 Kim et al.
numbers of tandem mutations in Pms22/2 mice in contrast
to the report by Winter et al. (14). The proportion of mu-
tations from G and C nucleotides is significantly greater in
Mlh12/2 and Pms22/2 mice than in wild-type mice. In-
creased mutations from G and C nucleotides have been re-
ported in Msh22/2 mice (13, 20) but in analogous studies
comparable alterations are not found in Pms22/2 or Mlh1
mice (14, 27). This discrepancy is unexplained. Our analy-
sis of Mlh12/2 and Pms22/2 mice indicates that the increase
in mutations from G and C nucleotides is the effect of
the lack of MMR function in general and not the effect of
the lack of functional mispair binding proteins such as
Msh2/3/6.
The Effect of Mlh1 Disruption Is More Pronounced in Peyer’s
Patch B Cells. Frey et al. (22) recently reported that Msh2
deficiency interferes with the accumulation of high num-
bers of mutations in Peyer’s patch GC B cells. We wanted
to ascertain whether the effect of disruption of the Mlh1
gene is similar in chronically stimulated B cells from Peyer’s
patches. 14-wk-old littermates, Mlh12/2 and Mlh11/1,
were used in the study. The mice were killed and Peyer’s
patches were dissected out from the intestines of these mice.
GC B cells were then isolated by flow cytometry. Cloning
and analysis of the EPS transgene were carried out as for
the splenic GC B cells. In addition to restriction fragment
length variance analysis, single strand conformation poly-
morphism (SSCP) analysis was carried out in identifying
clones with somatic mutations. For wild-type mice, a total
of 82 mutations from 24 clones were identified for a muta-
tion frequency of 6.5 3 1023 (Fig. 4 A). This mutation fre-
quency represents an z38% increase from the mutation
frequency found in the splenic GC B cells of wild-type
mice. The total number of mutations found in Mlh12/2 was
53 in 29 clones analyzed (Fig. 4 B). The mutation fre-
quency was 3.5 3 1023, which is not significantly different
from that of the splenic GC B cells of Mlh12/2 mice (2.9 3
1023) but is twofold less than that of Peyer’s patch cells of
wild-type mice (P 5 0.02) (Table III). An increase in mu-
tations from G and C nucleotides was again observed in the
Peyer’s patch B cells of Mlh12/2 mice. We also noted that
clones with high numbers of mutations were much re-
duced in Mlh12/2 mice (Fig. 5). About 65% of mutated
clones from Mlh12/2 contained a single mutation, whereas
z75% of the mutated clones from wild-type mice con-
tained multiple mutations, up to 16 mutations per clone. In
their analysis of Msh22/2 mice, Frey et al. (22) observed a
great increase in the microsatellite instability in Peyer’s
patch GC B cells (PNAhi) compared with non-GC B cells
from Peyer’s patches (PNAlo). We analyzed the stability of
CA nucleotide repeat microsatellites at the SSR D4Mit42
locus in Mlh12/2 mice, and observed that Peyer’s patch
GC B cells contained deletions or insertions in the
D4Mit42 locus at a frequency of 11.5% (9 out of 78) (Fig.
6). Non-GC B cells showed a microsatellite instability at a
three times lower frequency of 3.6% (3 out of 84). It seems
that the accumulation of mutations in Peyer’s patch cells is
affected by Mlh1 disruption as well as by Msh2 disruption.
Discussion
There Are No Gross Immune Defects in Mlh12/2 or Pms22/2
Mice. MMR-deficient mice, Msh22/2, Mlh12/2, or Pms22/2,
have severe health problems relating to the gene disruption
(17–19). In all of these, a high incidence of cancer and a
dramatic increase in microsatellite instability is noted. Ad-
ditionally, Mlh1 or Pms2 gene disruption leads to abnor-
malities in meiosis and thus to fertility problems. However,
we did not find any gross defects in the immune function
of Mlh12/2 or Pms22/2 mice that might compromise the
somatic hypermutation process. The levels of serum Igs of
various isotypes were normal in the Pms22 and Mlh12
mice (data not shown), thus isotype switching appeared to
be normal. Also, when compared with the serum of wild-
type mice immunized at the same time, Mlh12/2 or Pms22/2
mice showed no discernible defect in immune response to
the heterologous antigens in SRBCs (data not shown). Early
B cell development in bone marrow was studied by FACS®
analysis. We did not see any consistent difference in popu-
lations of B220lo or B220hi cells or in IgM/IgD double pos-
itive cells (data not shown). No significant differences in GC
cells as assayed were noted; we found similar proportions of
B2201PNAhi cells in the spleens as well as the Peyer’s
patches of wild-type or MMR-deficient mice (data not
shown). These observations are in contrast to the recent find-
ing of defective immune responses in Msh2 knockout mice
(21, 28). It remains to be determined whether the differences
are due to the type of MMR defect studied (mutS homologue
Table II. Somatic Mutation in Vk167/PEPS Transgene from 
Splenic GC B Cells
Wild-type* Mlh12/2 Pms22/2
No. of clones 46 26 15
Total No. of mutations 113 41 27
Mutation frequency
in EPS (1023) 17.0 12.4 12.0
Mutation frequency
in flank (1023) 1.7 .75 1.3
Mutation frequency
total (1023) 4.7 2.9 3.3
Tandem mutations 2 0 1
% mutations from A‡ 27.3 29.0 22.7
% mutations from T‡ 15.9 2.3 0
% mutations from C‡ 35.1 32.5 17.3
% mutations from G‡ 21.7 36.2 60.0
See Table I for the properties of the mice used.
*Data in this column are from reference 26. Only those mutations
within the transgene sequences from nucleotides 408 to 916 were con-
sidered for this tabulation. For the nucleotide numbers, see Fig. 3.
‡Percentage of mutations from each nucleotide are corrected for the
base composition.26 Somatic Hypermutation and DNA Repair
versus  mutL homologue), the immunization schedules, or
perhaps background genes of the mouse strains studied.
Intrinsic Characteristics of Somatic Hypermutation Remain
Unaltered in MMR-deficient Mice. As with wild-type mice,
we found in the analysis of MMR-deficient mice that mu-
tations from A were much more frequent than were muta-
tions from T (Tables II and III). This bias of A over T has
been seen in most studies of Ig somatic hypermutation and
suggests that there is a strand bias and a nucleotide prefer-
ence (A or T) that are intrinsic to the mutation mechanism
(3). From previous study of the Vk167/PEPS transgene, it
was noted that the EPS fragment of the transgene that con-
tains six PvuII sites and seven EcoRV sites was an order of
magnitude more mutable than the rest of the VJ region
(26). We have proposed that the hypermutability may be
related to the highly stable RNA secondary structures pre-
dicted in the EPS region. The striking correlation between
the RNA stem formation energy and the location of highly
mutated sequences led us to suggest that the mutations
could be directed by the secondary structure of nascent RNA
transcripts and perhaps by the RNA polymerase pausing
due to such RNA secondary structure (26). In MMR-defi-
cient mice, we found that the hypermutability of the EPS is
intact (Tables II and III). Thus, the hypermutability of the
EPS sequence in wild-type and MMR-deficient mice is
most likely the consequence of the primary mechanism of
the introduction of the mutations (see below). We also found
that in Mlh12/2 mice, just as in wild-type mice, there exists
a mutation preference for certain nucleotides within the
EcoRV or PvuII sites (Fig. 7). Not enough data from
Pms22/2 mice were accumulated for analogous consider-
ation. Among the six nucleotides within the EcoRV sites,
Figure 3. Analysis of Vk167/
PEPS transgene mutations in
splenic GC B lymphocytes. The
original transgene sequences
from NT 408 to 916 are shown
in uppercase letters. Mutations
are indicated in lowercase letters.
The restriction sites within the
EPS are indicated by a line over
the sequence. E is an EcoRV
and P is a PvuII site. A D denotes
a deletion. (A) Mutations from
Mlh12/2 mice. (B) Mutations
from Pms22/2 mice.27 Kim et al.
T and A nucleotides at positions 3 and 4, respectively, are
much more frequently mutated than are the remaining four
nucleotides. Similarly, within the PvuII sites, the G nucleo-
tide at position 3 and the C nucleotide at position 4 are
much more frequently mutated. These preferred nucleo-
tides within the restriction sites correlate with the sequences
of known hot spots as described by Smith et al. (5). The di-
and trinucleotide hot spots listed by Smith et al. were de-
rived from mutations in noncoding (therefore unselectable)
regions of Ig genes and must reflect the targeting prefer-
ence ingrained in the Ig mutation mechanism. Rada et al.
(21) found that mutations were increasingly focused on the
mutational hot spots in Msh22/2 mice. The proportion of
mutations found at the hot spots was elevated from 8.2% in
wild-type mice to 25.1% in Msh22/2 mice. Our analysis of
Mlh1- or Pms2-deficient mice showed the persistence of
mutation hot spots within the EPS but not a noticeable in-
crease in hot spot focusing. The proportion of mutations
found in the hypermutable EPS in wild-type mice was
z40%, and the frequencies in Mlh1- and Pms2-deficient
mice were 51 and 44%, respectively. The discrepancy with
Rada et al. (21) could be due to the fact that the mutated
bases in their hot spots were biased toward G and C,
whereas ours were balanced for A, T, G, and C (Fig. 7).
Perhaps GC-rich hot spots are treated differently from
AT-rich hot spots in the primary mutation mechanism.
Thus, our analysis of Mlh12/2 and Pms22/2 mice shows
that several signature properties of Ig somatic hypermuta-
Figure 4. Analysis of Vk167/
PEPS transgene mutations in
Peyer’s patch GC B lympho-
cytes. (A) Mutations from wild-
type mice. (B) Mutations from
Mlh12/2 mice.28 Somatic Hypermutation and DNA Repair
tion remained unchanged in these MMR-deficient mice. A
preference for targeting A over T (in the case of the non-
transcribed strand of DNA) or of targeting T over A (in the
case of the transcribed strand), a strand bias, mutational hot
spots, and the hypermutability of the EPS are all observed
in the analysis of the unselectable Vk167/PEPS transgene
in the MMR-deficient backgrounds. The implication is
that MMR proteins are not required for the primary step of
introducing Ig somatic hypermutations, and also, that the
absence of functional MMR does not alter the primary
mechanistics of somatic hypermutation.
Mutation Spectra of Mlh12/2 Mice Are Similar to Those of
Msh22/2 Mice. Recently, a number of labs reported that
MMR deficiency in mice results in altered mutation spec-
tra of Ig gene somatic hypermutation. One of the conflict-
ing points among these reports is that even though both
Msh2 and Pms2 are essential factors in MMR function,
Msh2 and Pms2 deficiency reportedly carry different con-
sequences for Ig hypermutation. Phung et al. (20) reported
increased mutation from G and C nucleotides in Msh22/2
mice, whereas an increase in tandem mutations was noted
in Pms22/2 mice (14). This has led to speculation that the
presence or absence of certain functional mismatch binding
complexes (Msh2/3 heterodimers or Msh2/6 hetero-
dimers) might differentially affect the final outcome of the
somatic hypermutation process (22, 29). In addition, evi-
dence from knockout mice suggests that Msh2, Mlh1, or
Pms2 gene products are involved in more than postreplica-
tive DNA MMR and perhaps each of these factors might
be involved in some unique function. For example, Msh2-
deficient mice are fertile, whereas Mlh1 deficiency leads to
both male and female infertility and Pms2 deficiency leads
only to male infertility (17, 18). This may imply that Mlh1
and Pms2 perform a role, at least in meiosis, independent of
Msh2 and perhaps independent of each other. However,
we have found that disruption of the MutL homologues
Mlh1 and Pms2 result in altered mutation spectra very sim-
ilar to those seen in Msh22/2 mice. There is a noticeable
increase in mutations arising from G or C nucleotides in
both Mlh12/2 and Pms22/2 mice. On the other hand, we did
not observe an increase in tandem mutations in our analysis
of Pms22/2 mice. This new evidence suggests that the al-
tered spectra of mutations, that is, the increase in mutations
from G and C nucleotides, are due to the absence of DNA
Figure 5. Mutation accumulation in Peyer’s patch B cells. Each bar
represents the percentage of Vk167/PEPS clones with a given number of
mutations. The distribution is calculated from the total number of clones
analyzed as indicated in Table III.
Figure 6. Microsatellite insta-
bility in Peyer’s patch B lympho-
cytes of Mlh12/2 mice. PNAhi
indicates the B2201PNAhi cell
population (GC B cells) and
PNAlo indicates the B2201PNAlo
cell population (non-GC B
cells). Each lane contains the product of a single PCR reaction with about
one cell equivalent of genomic DNA as template. Primers specific to
D4Mit42 SSR locus are used in the PCR. Three out of nine separate re-
actions from the PNAhi population show instability in CA repeats (indi-
cated by an asterisk), as evidenced by the appearance of the shorter PCR
product. All reactions from the PNAlo population show the PCR prod-
ucts of the correct length (102 nucleotides).
Table III. Somatic Mutation in Vk167/PEPS Transgene from 
Peyer’s Patch GC B Cells
Wild-type Mlh12/2
No. of clones 24 29
Total No. of mutations 82 53
Mutation frequency in EPS (1023) 13.5 12.9
Mutation frequency in flank (1023) 4.9 1.4
Mutation frequency total (1023) 6.5 3.5
% mutations from A* 43.7 21.2
% mutations from T* 17.2 13.2
% mutations from C* 22.3 43
% mutations from G* 16.8 22.6
See Table I for the properties of mice used.
*Percentage of mutations from each nucleotide are corrected for the
base composition.
Figure 7. Mutation distribution within EcoRV or PvuII sites of the
EPS sequence. Mutations from all six PvuII sites and all seven EcoRV
sites are combined. Each bar represents the percentage of mutations at the
specific location within the restriction recognition site out of total muta-
tions. For example, the percentage of mutation at G nucleotide at posi-
tion 3 of the PvuII site equals the number of mutations at G in all PvuII
sites divided by the number of total mutations. Data from the analysis of
splenic GC B cells and the analysis of Peyer’s patch GC B cells were com-
bined for this figure.29 Kim et al.
MMR function in general and not to the loss of any diver-
gent function of any one of the MMR proteins. Another
similarity between Msh22/2 and Mlh12/2 mice is the ab-
sence of highly mutated clones among Peyer’s patch B cells.
Frey et al. (22) suggested that the dramatic increase in micro-
satellite instability in Peyer’s patch GC B cells observed in
Msh22/2 mice is responsible for the lack of the accumula-
tion of mutations. Our observation of the increase in micro-
satellite instability in Peyer’s patch GC B cells of Mlh12/2
mice supports this proposal. GC B cells in Peyer’s patches
are highly proliferative and so the DNA damage (such as mi-
crosatellite instability) due to MMR deficiency could accu-
mulate to a high degree, causing elimination of GC B cells
after fewer rounds of mutation compared with wild-type
mice. The effect of microsatellite instability and accumula-
tive DNA damage is not as pronounced in splenic GC B
cells. In spleen, GCs form in response to a recent antigenic
stimulation and exist only for a short time (z3 wk),
whereas in Peyer’s patches the presence of food and bacte-
rial antigens lead to chronic stimulation of GC B cells (1).
How Is MMR Involved in Ig Gene Somatic Hypermutation?
During normal DNA replication, errors are corrected first by
the proofreading activity of the DNA polymerase itself
and then by postreplication DNA MMR. Postreplication
MMR would not affect somatic mutation patterns unless
the point mutations were introduced during S phase DNA
replication. Recent evidence is strong that somatic muta-
tion occurs during transcription (6, 8). There is no real evi-
dence that it occurs during the S phase of the cell cycle.
However, MMR proteins also seem to be involved in tran-
scription-coupled repair of UV-damaged DNA in associa-
tion with the NER process in Escherichia coli and in humans
(30, 31). Mismatch-deficient human cell lines from heredi-
tary nonpolyposis colorectal cancer patients lack the prefer-
ential repair of the transcribed strand of DNA (30). This
implies that the MMR function may be present during in-
terphase of the cell cycle and can function apart from the
DNA replicative machinery. Several possible ways by which
the MMR mechanism can contribute to the somatic hy-
permutation of Ig genes have been discussed previously.
First, as Cascalho et al. (32) proposed, it can act to “fix” the
mutations introduced in one of the strands by correcting
the wrong strand of DNA. Mismatch repair deficiency, in
this case, would lead to much reduced somatic hypermuta-
tion frequencies. However, several reports, including ours
presented here, noted that no drastic decrease in mutation
frequency exists in Msh22/2, Pms22/2, or Mlh12/2 mice. On
the other hand, MMR might normally be downregulated
in the GC B lymphocytes so as to allow the mutations to go
uncorrected. The fact that somatic hypermutation occurs in
MMR-deficient mice is compatible with this proposal.
However, the mutation spectrum should be unchanged and
the mutation frequency should be increased rather than de-
creased in these knockout mice if MMR were simply de-
creased in the course of the normal Ig somatic hypermuta-
tion process. The altered mutation spectra in MMR-deficient
mice were clearly observed by several labs using several dif-
ferent systems: Vl1 gene sequences from l11 memory B
cells of nitrophenyl-chicken g-globulin–immunized mice
(13), rearranged VkOX1 gene sequences from the spleen of
oxazolone-immunized mice (20), the JC intronic region of
rearranged heavy chain genes in Peyer’s patch PNAhi cells
(22), and, in this study, an unselectable transgene with a
hypermutable insert both in spleens of SRBC-immunized
mice and in Peyer’s patches of old mice. Furthermore, re-
cent reports indicated that MMR activity, as measured in
an in vitro assay, is normal in isolated human centroblast
cells (33) that are equivalent to GC (B2201PNAhi) B cells
in mice. Thus, it is unlikely that downregulation of MMR
is a normal mechanism to induce/enhance somatic hyper-
mutation.
The fact that the mutation spectrum is altered in a very
similar way in Msh22/2, Mlh12/2, and Pms22/2 mice sug-
gests that an active MMR complex is present in GC B
lymphocytes of normal mice and that it influences the out-
come of somatic hypermutation by preferentially correct-
ing some of the mutations introduced.
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